Detection of Mutations in Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Patients
碩士 === 長庚大學 === 醫學生物技術研究所 === 97 === Mutation of epidermal growth factor receptor (EGFR) in lung cancer is a predictive factor for response to therapeutic drugs, gefitinib (Iressa) and erlotinib (Tarceva). However, detection of EGFR mutation in clinical samples is difficult as the mutant allele usua...
Main Authors: | Ji Ci Jhou, 周吉麒 |
---|---|
Other Authors: | C. C. Chiou |
Format: | Others |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/64593605804720452725 |
Similar Items
-
Epidermal Growth Factor Receptor Mutations and Radiotherapy
in Non-small Cell Lung Cancer
by: Xing ZHONG, et al.
Published: (2013-03-01) -
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
by: Connor O’Leary, et al.
Published: (2020-09-01) -
Evaluation of current methods to detect the mutations of epidermal growth factor receptor in non-small cell lung cancer patients
by: Obradovic Jasmina, et al.
Published: (2012-12-01) -
Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer
by: Vijaya Raj Bhatt, et al.
Published: (2017-06-01) -
Optimal Therapeutic Strategy for Non-small Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor
by: Zhong SHI, et al.
Published: (2015-02-01)